Berger Financial Group, Inc - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 100 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berger Financial Group, Inc ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,913
-52.4%
10,9290.0%0.00%
-66.7%
Q2 2023$25,028
-5.8%
10,9290.0%0.00%0.0%
Q1 2023$26,558
+27.2%
10,9290.0%0.00%0.0%
Q4 2022$20,874
-19.7%
10,9290.0%0.00%
-25.0%
Q3 2022$26,000
+30.0%
10,9290.0%0.00%
+33.3%
Q2 2022$20,000
-13.0%
10,9290.0%0.00%0.0%
Q1 2022$23,00010,9290.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders